Annual report pursuant to Section 13 and 15(d)
Cover
Document and Entity Information
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements of Operations
Consolidated Statements of Changes in Stockholders' Equity
Consolidated Statements of Cash Flows
Notes to Financial Statements
Description of Business, Liquidity and Capital Resources
Summary of Significant Accounting Policies
Balance Sheet Disclosures
Reverse Merger and Private Placement
Loss Per Share
Stockholders' Equity
Commitments and Contingencies
Income Taxes
Revisions of Financial Statements for the Fiscal Quarters during Fiscal Years 2019 and 2018
Subsequent Events
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Balance Sheet Disclosures (Tables)
Stockholders' Equity (Tables)
Income Taxes (Tables)
Revisions of Financial Statements for the Fiscal Quarters during Fiscal Years 2019 and 2018 (Tables)
Notes Details
Description of Business, Liquidity and Capital Resources (Details)
Summary of Significant Accounting Policies (Details)
Balance Sheet Disclosures (Details)
Balance Sheet Disclosures (Details 1)
Balance Sheet Disclosures (Details Textual)
Reverse Merger and Private Placement (Details)
Loss Per Share (Details)
Stockholders' Equity (Details)
Stockholders' Equity (Details Textual)
Commitments and Contingencies (Details)
Income Taxes (Details 1)
Income Taxes (Details 2)
Income Taxes (Details 3)
Income Taxes (Details Textuals)
Revisions of Financial Statements for the Fiscal Quarters during Fiscal Years 2019 and 2018 (Details)
Subsequent Events (Details)
Stockholders' Equity (Tables)
v3.19.2
Stockholders' Equity (Tables)
12 Months Ended
Jun. 30, 2019
Equity [Abstract]
Schedule of stock warrants
Shares under warrants
Weighted average exercise price
Weighted average remaining life
Aggregate intrinsic value
Outstanding at July 1, 2017
-
Issued
5,993,750
$
11.50
Exercised
-
Expired/cancelled
-
Outstanding at June 30, 2018
5,993,750
11.50
4.61
Issued
189,365
11.50
Exercised
-
Expired/cancelled
-
Outstanding at June 30, 2019
6,183,115
$
11.50
3.72
$
2,473,000
X
- References
No definition available.
+ Details
Name:
KERN_ScheduleOfShareBasedCompensationStockWarrantsActivityTableTextBlock
Namespace Prefix:
KERN_
Data Type:
nonnum:textBlockItemType
Balance Type:
na
Period Type:
duration
X
- References
No definition available.
+ Details
Name:
us-gaap_EquityAbstract
Namespace Prefix:
us-gaap_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration